The fifth episode of "Best of UEG Week 2024" is all about oncology. Julia Mayerle sits down with Thomas Seufferlein to discuss all the best research in oncology presented during UEG Week this year.

Presentations and papers mentioned:

• Why ask for MSI analysis on the first tissue biopsy? @ 03:00
• How I treat MSI colon and early rectal cancer @ 03:00
• Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study. @ 04:50
• Targeting kRAS in GI cancer @ 15:50
• Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 @ 22:40